APB-101

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameAPB-101

Drug Alias NameAPB-101

ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vectorSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionAlpha-1-antiproteinase modulators

TargetsAlpha-1-antiproteinase

Therapy Area/Indicationsalpha 1-Antitrypsin Deficiency

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Massachusetts Medical School

China Registration ClassN/A

Develop Information

Active CompaniesApic Bio

Inactive CompaniesN/A

Active Indicationsalpha 1-Antitrypsin Deficiency

Inactive IndicationsN/A

Other Information

ATC CodeN/A